RxDoctor Payments Data

Deborah Oshields

Obstetrics & Gynecology · Augusta, GANPI 1285644781

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.3% of the total across 179 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by Novo Nordisk at 24.3% of the total. Reporting peaked in 2022 at $894 and has fallen 97.5% since, to $22 in 2024.

$2,523in general payments, 2019–2025

Across 179 payments — averaging $14.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$613
  • AbbVie$419
  • Bayer$157
  • Currax Pharmaceuticals LLC$127
  • Duchesnay USA Incorporated$114
  • Pfizer$91
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$2,43196%
  • Education$924%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,523 in reported general payments places this provider in the 75th percentile of 1,324 obstetrics & gynecology providers in Georgia.

See all obstetrics & gynecology providers in Georgia →

Other obstetrics & gynecology in Augusta

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →